绥美凯多少钱？

Currently, it has received marketing approval from the China Food and Drug Administration (CFDA). As an innovative single-pill compound preparation with obvious clinical therapeutic advantages, it can provide great convenience for the treatment of AIDS patients. As a new AIDS treatment drug, Suimeikai has received priority review and approval from the CFDA.

Suimeikai (alias: dolutegravir tablets) is the only three-in-one compound drug containing dolutegravir (DTG). It has the characteristics of high efficacy, good tolerance, high resistance barrier, and few drug interactions. One tablet per day can significantly reduce the medication burden of AIDS patients, thereby improving patients' medication compliance and significantly improving their quality of life.

Thirty years ago, AIDS was a fatal disease, but now, through the joint efforts of doctors and scientists, significant progress has been made in AIDS treatment, and AIDS is now becoming a chronic disease that can be completely controlled.

Through effective AIDS drug treatment, we can see that the life spans of AIDS patients and healthy people are getting closer and closer. Therefore, drug compliance and convenience of medication play an increasingly important role in further improving the quality of life of patients. The approval of Suimeikai has filled this gap and met the urgent need for convenient medication use by doctors and patients.

According to Medical Travel, since Suimeikai is an imported original drug in China, it is very expensive and most patients cannot afford it. Therefore, many patients choose Suimeikan, which is launched in India. How much does the Indian version of Suimeikan cost?

Produced by the Indian company Emcure, a box of 30 tablets sells for about RMB 1,000. The price cannot be determined due to floating exchange rates. Please consult Medical Travel for the specific price.

Recommended related hot articles: /newsDetail/71976.html